SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14C - Definitive information statement relating to merger or acquisition:
SEC Accession No. 0001493152-20-016967
Filing Date
2020-08-31
Accepted
2020-08-31 07:00:33
Documents
4
Effectiveness Date
2020-08-31

Document Format Files

Seq Description Document Type Size
1 defm14c.htm DEFM14C 3844948
2 exb_001.jpg GRAPHIC 223346
3 exb_002.jpg GRAPHIC 208313
4 report_001.jpg GRAPHIC 26725
  Complete submission text file 0001493152-20-016967.txt   4477820
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFM14C | Act: 34 | File No.: 000-52218 | Film No.: 201149766
SIC: 2834 Pharmaceutical Preparations